Aquestive director Daly receives 57,000 stock options

The 57,000 options vest in three equal annual installments beginning November 6, 2027, and expire November 6, 2036.

Available on EDGAR 11/10/2026 - 10:43 AM EST Accepted by SEC EDGAR 11/10/2026 - 10:42 AM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Aquestive Therapeutics, Inc. director Richard J. Daly acquired a grant of 57,000 non-qualified stock options on November 6, 2026, with an exercise price of $3.61 per share. The reported resulting position is 57,000 options, exercisable for common stock and expiring November 6, 2036.

Insider Trade Summary

Grant/Award: 57,000 shares

Grant/Award 1 txn

Insider Daly Richard J

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Non-Qualified Stock Option (right to buy) F1	57,000	$0.00	$0.00

Holdings After Transaction: Non-Qualified Stock Option (right to buy) — 57,000 options (Direct)

Holdings Before and After: Non-Qualified Stock Option (right to buy), 0 to 57,000 options (Direct)

Footnotes (1)

1. F1. The option vests in three equal annual installments beginning on November 6, 2027.

Key Figures

Non-qualified stock options granted: 57,000 options Exercise price: $3.61 per share Vesting installments: 3 equal annual installments +1 more

4 metrics

Non-qualified stock options granted 57,000 options Granted November 6, 2026

Exercise price $3.61 per share Option award granted November 6, 2026

Vesting installments 3 equal annual installments Beginning November 6, 2027

Option expiration November 6, 2036 Option award

Key Terms

Non-Qualified Stock Option, vests, annual installments

3 terms

Non-Qualified Stock Option financial

"Non-Qualified Stock Option (right to buy)"

A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.

vests financial

"The option vests in three equal annual installments"

annual installments financial

"three equal annual installments beginning on November 6, 2027"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How does Richard J. Daly's AQST option award vest?

The 57,000 options vest in three equal annual installments beginning November 6, 2027. The option grant expires November 6, 2036.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Daly Richard J

(Last) (First) (Middle)

C/O AQUESTIVE THERAPEUTICS, INC.

184 LIBERTY CORNER DRIVE, SUITE 305

(Street)

WARREN NEW JERSEY 07059

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Aquestive Therapeutics, Inc. [ AQST ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$3.61	11/06/2026		A		57,000		(1)	11/06/2036	Common Stock	57,000	$0	57,000	D

Explanation of Responses:

1. The option vests in three equal annual installments beginning on November 6, 2027.

Remarks:

	/s/ Thomas Zalewski, as Attorney-In-Fact	11/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)